SEATTLE –– Ground broke Wednesday on a new 197,000-sq.-ft., 9-story, purpose-built life sciences development in downtown Seattle named 222 Fifth. The project is a joint venture between LPC West and Intercontinental Real Estate Corporation, with CBRE serving as leasing advisor. 222 Fifth is LPC’s second life sciences project in Seattle. Construction is scheduled to complete […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
An Angelo Gordon-affiliated owner handed The Baxter to Keelbase Capital through a...
ByThe RegistryOctober 21, 2026Ascent South Lake Union and Marlowe, the 432-unit pair Blackstone bought for...
ByThe RegistryOctober 21, 2026The Navy has opened bidding on a multibillion-dollar contract to build a...
ByThe RegistryOctober 21, 2026Desimone Enterprises has bought Vista Del Rio, a 213-site, 55-and-older manufactured home...
ByThe RegistryOctober 21, 2026